Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089104 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
18,672
Total Value
$160,261.20
P&L
+inf% (+$238,215.78)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Medical Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 11,643 | $0.00 | $0.00 | 83,173 | Direct | โ | View Details | |
EVP and Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 7,029 | $22.80 | $160,261.20 | 76,301 | Direct | โ | View Details |